경도 인지 장애와 알츠하이머 병 환자의 혈액 검사 지표 비교

키워드

참고문헌 (39)

1. Petersen RC, "Current concepts in mild cognitive impairment", Arch Neuro, 58, pp.1985~1992 (2001)
2. Peterson RC, "Mild cognitive impairment:current research and clinical implications", Semin Neurol, 27, pp.22~31 (2007)
3. Petersen RC, "Mild cognitive impairment:Clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
4. Winblad B, "Mild cognitive impairment beyond-controversies,towards a consensus:Report of the International Working Group on Mild cognitive impairment", J Intern Med, 256, pp.240~246 (2004)
5. Andreasen N, "Evaluation of CSF-tau and CSF-Aβ-42 as diagnostic markers for Alzheimer’s disease in clinical practice", Arch neurol, 58, pp.373~379 (2001)
6. Clarke R, "Folate,vitamine B12,and serum total homocysteine levels in confirmed Alzheimer’s disease", Arch neurol, 55, pp.1449~1455 (1998)
7. Doyle RM, "Homocysteine and Alzheimer’s disease", J Am Geriatr Soc, 49, pp.S150~ (2001)
8. McKhann G, "Clinical diagnosis of Alzheimer’s disease:report od the NINCDS-ADRDA Work Group under the auspices of Department of Health Services Task Force on Alzheimer’s disease", Neurology, 34, pp.939~944 (1984)
9. Hanninen T, "Prevalence of ageing-associated cognitive decline in an elderly population", Age Ageing, 25, pp.201~205 (1996)
10. Obadia Y, "The PREMAP Study:prevalence and risk factors of dementia and clinically diagnosed Alzheimer’s disease in provence,France:Prevalence of Alzheimer’s disease in Provence", Eur J Epidemiol, 13, pp.247~253 (1997)
11. Neuzil J, "Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol,inhibiting plasma and low denstiy lipoprotein lipid peroxidation", J Biol Chem, 269, pp.16712~9 (1994)
12. Stocker R, "Bilirubin is an antioxiant of possible physiological importance", Science, 235, pp.1043~1046 (1987)
13. Schwertner HA, "Association of smoking and low serum bilirubin antioxidant concentrations", Atherosclerosis, 136, pp.383~387 (1998)
14. Schwertner HA, "Association of low serum concentraion of bilirubin with increased risk of coronary artery disease", Clin Chem, 40, pp.18~23 (1994)
15. Lyras L, "An assessment of oxidative damage to protein,lipid,and DNA in brain from patient with Alzheimer’s disease", J Neurochem, 68, pp.2061~2069 (1997)
16. Lovell MA, "Increased DNA oxidation and decreased levels of repair products in Alzheimer’s disease ventricular CSF", J Neurochem, 72, pp.771~776 (1999)
17. Gabbita SP, "Increased nuclear DNA oxidation in the brain in Alzheimer’s disease", J Neurochem, 71, pp.2034~2040 (1998)
18. Wayner DD, "The relative contribution of vitamin E,uratem ascorbate and proteins to the total peroxyl radical-trapping antioxidatant activity of human blood plasma", Biochem Biophys Acta, 924, pp.408~419 (1987)
19. Soriani M, "Antioxidant potential of anaerobic human plasma:role of serum albumin and thiols as scavengers of carbon radicals", Arch Biochem Biophys, 312, pp.180~188 (1994)
20. Stocker R, "Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxidase in bile", Proc Nat Acad Sci USA, 84, pp.8130~8134 (1987)
21. Schram MT, "Serum calcium and cognitive function in old age", J Am Geriatr Soc, 55, pp.1786~1792 (2007)
22. Lesser G, "Elevated serum total and LDL cholesterol in very old patients with Alzheimer’s disease", Dement Geriatr Cogn Disord, 12, pp.138~145 (2001)
23. Yaffe K, "Serum lipoprotein levels,statin use,and cognitive function in older women", Arch Neurol, 59, pp.378~384 (2002)
24. Romas SN, "APOE genotype, plasma lipid, lipoproteins, and AD in community elderly Neurology", 53, pp.517~521 (1999)
25. Reuben DB, "The predictive value of combined hypoalbuminemia and hypocholestrolemia in high functioning communitydwelling older persons:MacArther Studies of Successful Aging", J Am Geriatr Soc, 47, pp.402~406 (1999)
26. Pappolla MA, "Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology", Neurology, 61, pp.199~205 (2003)
27. Stewart R, "26-year change in total cholesterol levels and incident dementia.The Honolulu-Asia Aging Study", Archives of Neurology, 64, pp.103~107 (2007)
28. Yaffe K, "The metabolic syndrome,inflammation and risk of cognitive delcine", JAMA, 292, pp.2237~2242 (2004)
29. Razay G, "The Metabolic Syndrome and Alzheimer Disease", Arch Neurol, 64, pp.93~96 (2007)
30. Stewart R, "Type 2 diabetes mellitus,cognitive impairment and dementia", Diabet Med, 16, pp.93~112 (1999)
31. Kalmijn S, "Glucose intolerance,hyperinsulinaemia and cognitive function in a general population of elderly men", Diabetologia, 38, pp.1096~1102 (1995)
32. Van Swieten JC, "Hypertension in eldery is associated with white matter lessions and cognitive decline", Ann Neurol, 30, pp.825~830 (1991)
33. Waldstein SR, "Nonlinear relations of blood pressure to cognitive function:the Baltimore Longitudinal Study of Aging", Hypertension, 45, pp.374~379 (2005)
34. Hebert LE, "Blood pressure and latelife cognitive function change:a biracial longitudinal population study", Neurology, 62, pp.2021~2024 (2004)
35. Kalmijn S, "Metabolic cardiovascular syndrome and risk of demetia in Japanses-American elderly men.The Honolulu Asia aging study", Arterioscler Thromb Vasc Biol, 20, pp.2255~2260 (2000)
36. Whitmer RA, "Midlife cardiovascular risk factors and risk of demetia in late life", Neurology, 64, pp.277~281 (2005)
37. Scarmeas N, "Mediterranean diet and risk for Alzheimer’s Disease", Ann Neurol, 59, pp.912~921 (2006)
38. Morris MC, "Consumprion of fish and n-3 fatty acids and risk of incident Alzheimer Disease", Arch Neurol, 60, pp.940~946 (2003)
39. Rahman A, "Dietary factors and cognitive impairment in community-dwelling elderly", Journal of Nutrition Health Aging, 11, pp.49~54 (2007)

관련 논문AI추천